{"name":"Advaccine (Suzhou) Biopharmaceuticals Co., Ltd.","slug":"advaccine-suzhou-biopharmaceuticals-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Respiratory Syncytial Vaccine","genericName":"Respiratory Syncytial Vaccine","slug":"respiratory-syncytial-vaccine","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Respiratory Syncytial Vaccine","genericName":"Respiratory Syncytial Vaccine","slug":"respiratory-syncytial-vaccine","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPdDVBUFFaYXNQRFhNVDd0QjFKR00wWWE4V0M2dF8yeUZCdGVBNFRyc0dIdGNWSXpCLTNwWjR0MG9PWTJSOExVOEJVekhwcGRCMlNXdnMxMjdmNEZJbW5MaWxXS3hya09mSE5TeUNlRTFyQzJZNHQ3V2J1Vm9GZFVldjBuX09hVlU?oc=5","date":"2023-04-26","type":"pipeline","source":"IBEF","summary":"India on the path to becoming a Bio-manufacturing Hub - IBEF","headline":"India on the path to becoming a Bio-manufacturing Hub","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNZ3dmQVliZDhzakJmcHlIZDZtd3dlXzRlc2pvYk5iUmh2NEpVRE1KNEtRNmRqWjBFcTVvWlAtVVhJOEVIV2xHcHNULThDelZ1eHBlaUFzbFpLR0pTdjhfM0FLeEItSjA5S0tKbkdaZTNxVy1IODhBNk9aTjJwSnZXTk9rbUZ1QUFKd3pudkczTWhObHJtY2tBXzlVRThZUUwyVm1SRUJjSTRhV3NxVkM4eXZ3?oc=5","date":"2022-05-11","type":"pipeline","source":"BioWorld News","summary":"New CEO Shea to lead Inovio’s shift to COVID-19 vaccine booster strategy - BioWorld News","headline":"New CEO Shea to lead Inovio’s shift to COVID-19 vaccine booster strategy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTFBQajk4d1J0M0lOU1ZkVUt6ZmR1UlJPZWg3LWZ4RzFpNHowMTZrMElkQ0Fpa0hRNHhKbUFtRklrZHF1MTZ6SnYySjgxeWFLUC14NUVMSVNJZjJiazVZRUk0ZjljYWQ3RHpnSkFoYw?oc=5","date":"2021-12-21","type":"regulatory","source":"Investor's Business Daily","summary":"Is Inovio Stock A Buy After The FDA Removed Its Hold On Covid Vaccine Testing? - Investor's Business Daily","headline":"Is Inovio Stock A Buy After The FDA Removed Its Hold On Covid Vaccine Testing? - Investor's Business Daily","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQMW1pLWdZTDFNV3VFQXo4Y3FieVZmSFl5YlFaM1R0Mm9RUDgxdWJYN0xWSzg1Vmg0VlVPeDk3TERMT0dvbW5wMlotRXBlQl81ZlJocWlQVjd6djEtSEFpWWRmb1RZSElBWUQwQmp4cW1jd216Z2NVVW1FT2ZGdUg3TGoyYkF3Q1J3Z19KTGNn?oc=5","date":"2021-08-03","type":"pipeline","source":"BioWorld News","summary":"Is the finish line in sight for DNA vaccines? - BioWorld News","headline":"Is the finish line in sight for DNA vaccines?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOZFMxSnp0dkZrdU92RU1hRWxjc3BtbmJtMDdQNURyUXk4SzA5NENFTElCaFZudEtHUzdsQ29PU3Z5NTRlQUlvMUZCaWozYXBUUndWVFpLcXdwRWNjOVcxeTh6aHp6Z2tJa3V5Ti03SjlxSG1JcU5LX0N6RHJ2QnZ0MWRnb3E?oc=5","date":"2021-01-05","type":"trial","source":"cyprus-mail.com","summary":"Inovio to begin late-stage Covid-19 vaccine study in second quarter - cyprus-mail.com","headline":"Inovio to begin late-stage Covid-19 vaccine study in second quarter - cyprus","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}